In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
In March, the Centers for Disease Control and Prevention launched phase 1c of its COVID-19 vaccine roll-out plan. Diabetes patients and patients with other underlying medical conditions are included on the list. Learn more in this article.
Endocrinology Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Many healthcare providers are unclear as to when a request is made by an individual pursuant to a HIPAA authorization versus a HIPAA access request, particularly when a patient wants records to be sent to a third party, a HIPAA compliance officer at a law firm explained.
Obesity is a clear risk factor for COVID-19 complications, so what can nurse practitioners and physician assistants do to keep their patients with obesity safe and healthy?
Nursing experts discuss strategies to reduce vaccine hesitancy and access barriers in Black, Hispanic, Orthodox Jewish, and other underserved communities.
In a statement published in the Journal of Clinical Endocrinology and Metabolism, physicians from Johns Hopkins School of Medicine acknowledge the challenges minority populations may face within the healthcare system. They pose a larger question: Why does disparity exist?
A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.
Long-acting reversible contraception, such as hormonal and non-hormonal intrauterine devices (IUDs) and hormonal implants, have been proven safe and effective for adolescent patients.
